In my PhD training, I applied epidemiological methods to multi- ‘omics’ data identify risk markers for cardiovascular diseases. In this work, I gained expertise in statistical genetics, including association mapping, Mendelian randomization, and risk score curation. I also honed skills in classical epidemiology in a variety of projects. My training was supported by an F31-Diversity award (F31DK128990) and partially supported by the PRIME T32 training program (T32DK116672), both funded by the National Institutes of Health.

Featured manuscripts are below, and a full publication list can be found on Google, ResearchGate, or ORCID.

Selected First-Author Publications:

• Single-Ancestry versus Multi-Ancestry Polygenic Risk Scores for CKD in Black American Populations. Journal of the American Society of Nephrology. 2024

• A methylation risk score for chronic kidney disease: a HyperGEN study. Scientific Reports. 2024

• Metabolite profiles and DNA methylation in metabolic syndrome: a two-sample, bidirectional Mendelian randomization. Frontiers in Genetics. 2023

  • *Noted by the Editor as a “Rising Star in Epigenetics and Epigenomics”

• Differentially methylated DNA regions and left ventricular hypertrophy in African Americans: a HyperGEN study. Genes. 2022

• Neighborhood walkability as a predictor of incident hypertension in a national cohort study. Frontiers in Public Health. 2021